CIK 0001867096 · Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 871082097
- Phone
- 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,678,894
- in 11 filings, $1.7M under 10b5-1 plans
Net −$1,678,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-05 | McCulloch Kevin See Remarks | Sale 10b5-1 | −25,000 | $12.49 | $312K | 1,559,208 |
| 2026-11-02 | Pieper Steven See Remarks | Sale 10b5-1 | −5,000 | $10.23 | $51K | 1,346,053 |
| 2026-11-02 | Hecht Beth See Remarks | Sale 10b5-1 | −25,000 | $10.23 | $256K | 1,086,130 |
| 2026-11-02 | McCulloch Kevin See Remarks | Sale 10b5-1 | −15,000 | $10.23 | $153K | 1,584,208 |
| 2026-11-02 | Taddese Menassie Director | Grant or award | +22,365 | 22,365 | ||
| 2026-11-02 | Taddese Menassie Director | Grant or award · Stock Option (Right to Buy) | −31,499 | $10.17 | $320K | 31,499 |
| 2026-10-01 | Pieper Steven See Remarks | Sale 10b5-1 | −5,000 | $9.41 | $47K | 1,351,053 |
| 2026-10-01 | McCulloch Kevin See Remarks | Sale 10b5-1 | −15,000 | $9.41 | $141K | 1,599,208 |
| 2026-10-01 | Hecht Beth See Remarks | Sale 10b5-1 | −16,666 | $9.41 | $157K | 1,111,130 |
| 2026-09-28 | McCulloch Kevin See Remarks | Sale 10b5-1 | −25,000 | $10.00 | $250K | 1,614,208 |
| 2026-09-01 | McCulloch Kevin See Remarks | Sale 10b5-1 | −15,000 | $8.49 | $127K | 1,639,208 |
| 2026-09-01 | Pieper Steven See Remarks | Sale 10b5-1 | −5,000 | $8.50 | $43K | 1,356,053 |
| 2026-09-01 | Hecht Beth See Remarks | Sale 10b5-1 | −16,666 | $8.49 | $141K | 1,127,796 |
| 2026-08-12 | Pieper Steven See Remarks | Sale 10b5-1 | −5,000 | $8.50 | $43K | 1,361,053 |
| 2026-08-03 | McCulloch Kevin See Remarks | Sale 10b5-1 | −15,000 | $8.02 | $120K | 1,676,126 |
| 2026-08-03 | Hecht Beth See Remarks | Sale 10b5-1 | −16,666 | $8.01 | $134K | 1,144,462 |
| 2026-08-01 | Shannon John Patrick Jr See Remarks | Shares withheld for taxes | −36,645 | $8.08 | $296K | 2,898,933 |
| 2026-08-01 | McCulloch Kevin See Remarks | Shares withheld for taxes | −21,918 | $8.08 | $177K | 1,654,208 |
| 2026-07-07 | Pieper Steven See Remarks | Sale 10b5-1 | −27,600 | $8.52 | $235K | 1,366,053 |
| 2026-07-06 | Pieper Steven See Remarks | Sale 10b5-1 | −17,400 | $8.50 | $148K | 1,393,653 |
Page 1 of 10 · 200 trades